Slow Release of a Drug, TT-10, Improves Heart Attack Recovery

Jianyi Zhang

Jianyi “Jay” Zhang. Credit: UAB

Release of TT-10 from nanoparticles improved heart function after a heart attack, accompanied by increased cardiomyocyte proliferation and smaller infarct size in a mouse model.

A heart attack kills heart muscle cells, leading to a scar that weakens the heart, often leading to eventual heart failure. The lack of muscle repair is due to the very limited ability of mammalian heart muscle cells to proliferate, except for a brief period around birth.

Thus, a pharmaceutical product called TT-10, which acts through components of the Hippo-Yap signaling pathway to spur proliferation of heart muscle cells, was thought to offer promise to treat heart attacks. Intraperitoneal injections of TT-10 in a mouse heart-attack model several years ago at first promoted proliferation of heart muscle cells and showed declines in the size of the dead area of heart muscle, known as an infarct, one week after administration. However, those early improvements were followed by worsened cardiac function at later time points.

So, Jianyi “Jay” Zhang, M.D., Ph.D., and his University of Alabama at Birmingham Department of Biomedical Engineering colleagues asked a simple question: What would happen if TT-10 were loaded into nanoparticles made of poly-lactic-co-glycolic-acid, or PLGA, which would then allow the slow release of TT-10?

Slow release indeed turned out to be beneficial, as Zhang and UAB colleagues report in the journal JCI Insight. Nanoparticle-mediated, slow-release delivery of TT-10 enhanced the potency and durability of TT-10 treatment for repair of heart muscle in the mouse heart-attack model.

Injection of the TT-10 nanoparticles into the infarcted heart muscle improved heart function — as measured by significantly improved ejection fractions and functional shortening, and significant decreases in end-systolic diameters and end-diastolic diameters — as compared with groups of mice treated with saline, empty nanoparticles or direct TT-10 solution. Also, the TT-10 nanoparticle-treated hearts had significantly lower infarct sizes and lower heart-weight/body-weight ratios compared to the other three groups, which all had similar measurements. All these measures indicated improved heart function for the TT-10 nanoparticle group.

The researchers also measured the effects of TT-10 on the biology of heart muscle cells, known as cardiomyocytes, and on several markers of cell reproduction, both in culture and in the mouse heart-attack model.

Human induced pluripotent stem-cell cardiomyocytes grown in different concentrations of TT-10 showed increased molecular markers for proliferation, the S-phase of the cell cycle (when the cell replicates its genome content), the M-phase of the cell cycle (when the cell divides the copied DNA) and cytokinesis (when the cytoplasm of the two daughter cells is split in two). Peak activity was seen at TT-10 concentrations of 10 to 20 micromolar.

The cultured cardiomyocytes also showed significantly reduced programmed cell death, or apoptosis, and a significantly increased proportion of cardiomyocytes with the transcriptional co-activator Yap located in the nuclei. That presence of Yap in the nucleus, where it actively aids gene expression, is consistent with a role for Hippo-Yap signaling in cardiac regeneration, Zhang says.

Hearts treated with TT-10 nanoparticles in the mouse heart-attack model had dramatically more border-zone cardiomyocytes that showed markers for cell proliferation, M-phase growth and nuclear location of Yap at one week after infarction, compared to the other three treatment groups. The border zone is the area next to the infarct. Also, the TT-10 nanoparticle treatment appeared to promote blood vessel growth, called angiogenesis.

This suggests that the improvements in myocardial recovery observed in TT-10 nanoparticle-treated mice appeared to be, at least partially, attributable to the activation of Hippo-Yap signaling and cardiomyocyte proliferation, the UAB researchers say.

“Thus, our results suggest that PLGA nanoparticles could be used to improve the efficiency of treatment administration for numerous cardiovascular drugs,” Zhang said. “Furthermore, although the animals in our current investigation were treated with TT-10 nanoparticles via direct intramyocardial injections during open-chest surgery, PLGA nanoparticles are fully compatible with less invasive clinical delivery methods, such as catheter-based or echo-guided transthoracic myocardial injection.”

Reference: “TT-10-loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction” by Wangping Chen, Danielle Pretorius, Yang Zhou, Yuji Nakada, Jinfu Yang and Jianyi Zhang, 22 October 2021, JCI Insight.
DOI: 10.1172/jci.insight.151987

Co-authors with Zhang in the study are Wangping Chen, Danielle Pretorius, Yang Zhou and Yuji Nakada, UAB Department of Biomedical Engineering; and Jinfu Yang, Second Xiangya Hospital, Central South University, Changsha, China. Chen is a visiting scholar from Second Xiangya Hospital, Central South University.

Support came from National Institutes of Health grants HL114120, HL131017, HL149137 and HL134764.

Biomedical Engineering is a joint department of the UAB School of Medicine and the UAB School of Engineering. Zhang is professor and chair of the department, and he holds the T. Michael and Gillian Goodrich Endowed Chair of Engineering Leadership.

University of Alabama at Birmingham

Recent Posts

First Theorized 70 Years Ago – “Rippled Beta Sheet” Created for the First Time

University of California, Santa Cruz, scientists report the creation of three crystal structures of periodic…

October 3, 2022

Scientists Successfully Create Diamonds Out of Bottle Plastic

A research team utilizes laser flashes to replicate the interior of ice planets, which inspires…

October 3, 2022

Don’t Miss: Evenings With Giants, Mars Changes Course, and Meteors From Orion

What are some skywatching highlights in October 2022? Enjoy giant planets Jupiter and Saturn all…

October 3, 2022

Rewriting History – The First Full-Length Genomes for Homosporous Ferns

A new study reveals ferns' history of DNA hoarding and kleptomania. Ferns are infamous for…

October 3, 2022

New Research Could Change Our Understanding of Autism

Research on identifying facial emotional expressions may alter how we see autism. There is a…

October 3, 2022

Tremendous Potential – Vitamin K Found To Prevent Cell Death

Scientists discover a new function for a long-known molecule.  A team of researchers from Helmholtz…

October 3, 2022